CVS Health Scores A on VGM, Forecasts 6.1% Earnings Growth
CVS Health holds a Zacks Rank #3 (Hold) with a top-tier VGM Score of A and a Growth Style Score of B forecasting 6.1% year-over-year earnings growth for fiscal 2026. Four analysts raised EPS estimates by $0.01 to $7.16, and the company has averaged a 20.6% earnings surprise.
1. Zacks Rank and Style Scores
CVS Health holds a Zacks Rank #3 (Hold) rating, reflecting a neutral near-term outlook, combined with a VGM Score of A that integrates value, growth, and momentum metrics. The company also earns a Growth Style Score of B, indicating strong projected and historical earnings and sales momentum.
2. Analyst Revisions and Earnings Forecast
Over the past 60 days, four analysts have revised their fiscal 2026 EPS estimates for CVS upward by a total of $0.01, establishing a consensus forecast of $7.16 per share. This modest increase underpins the projected 6.1% year-over-year earnings growth for the current fiscal year.
3. Historical Earnings Surprise
CVS has delivered an average earnings surprise of +20.6%, showcasing its ability to exceed analysts’ expectations. This consistent outperformance may enhance investor confidence in the company’s capacity to sustain positive surprises.